A detailed history of Virtus ETF Advisers LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 16,727 shares of ZLAB stock, worth $414,996. This represents 0.2% of its overall portfolio holdings.

Number of Shares
16,727
Previous 16,727 -0.0%
Holding current value
$414,996
Previous $289,000 39.45%
% of portfolio
0.2%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.72 - $21.55 $56,444 - $88,656
4,114 Added 32.62%
16,727 $289,000
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $28,949 - $48,642
1,815 Added 16.81%
12,613 $202,000
Q4 2023

Feb 15, 2024

SELL
$22.97 - $30.58 $4,594 - $6,116
-200 Reduced 1.82%
10,798 $295,000
Q3 2023

Nov 07, 2023

SELL
$22.72 - $31.49 $32,376 - $44,873
-1,425 Reduced 11.47%
10,998 $267,000
Q2 2023

Aug 14, 2023

BUY
$25.3 - $39.67 $92,243 - $144,636
3,646 Added 41.54%
12,423 $344,000
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $4,591 - $7,311
152 Added 1.76%
8,777 $291,000
Q4 2022

Feb 14, 2023

SELL
$22.28 - $38.71 $26,446 - $45,948
-1,187 Reduced 12.1%
8,625 $264,000
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $4,890 - $7,391
143 Added 1.48%
9,812 $336,000
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $86,451 - $185,604
3,736 Added 62.97%
9,669 $335,000
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $177,930 - $340,985
3,241 Added 120.39%
5,933 $373,000
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $25,725 - $43,700
-245 Reduced 8.34%
2,692 $284,000
Q2 2021

Aug 10, 2021

BUY
$125.11 - $180.0 $367,448 - $528,660
2,937 New
2,937 $520,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.43B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.